Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2022-06-16
Original market date: See footnote 1
2021-06-15
Product name:
PERSERIS
Description:
SINGLE USE PREFILLED SYRINGES
DIN:
02507846
Product Monograph/Veterinary Labelling:
Date:
2023-05-25
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
HLS THERAPEUTICS INC
10 Carlson Court, Suite 701
Etobicoke
Ontario
Canada
M9W 6L2
Class:
Human
Dosage form(s):
Kit , Powder For Suspension, Sustained-Release
Route(s) of administration:
Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.08.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05AX08 RISPERIDONE
Active ingredient group (AIG) number:See footnote5
0124332014
Active ingredient(s) | Strength |
---|---|
RISPERIDONE | 120 MG / SYR |